UAMS/UALR Office of Communications
UAMS researcher William Culp, M.D., (right), and Doug Wilson of UALR (left) have developed a device to treat stroke
‘Halo-like’ device fits on head to quickly bust clots
A new device developed by a physician at the University of Arkansas for Medical Sciences and a researcher at the University of Arkansas at Little Rock could soon be available to treat stroke more effectively.
The ClotBust ER® fits on the head like a halo and delivers therapy to quickly bust clots that cause stroke.
It was developed by William Culp, M.D., professor of radiology, surgery and neurology and vice chairman of research at UAMS, and Doug Wilson, assistant director at the Graduate Institute of Technology at UALR.
Culp has spent many years studying therapy for stroke. One element of Culp’s work included using ultrasound in combination with the clot-busting drug tissue plasminogen activator (t-PA).
While looking into the treatment to dissolve clots in blood vessels, Culp realized one problem is getting the ultrasound to operate through the skull. Ultrasound can be delivered anywhere in a patient’s body unless the waves hit something hard like bone or something very soft, like air.
“We realized we had trouble delivering ultrasound to the vessels at the base of the brain,” Culp said. “The skull stopped the ultrasounds.”
He teamed with Wilson to brainstorm ideas about how to get the ultrasound waves to reach the clot in stroke patients.
“This is a great example of how faculty at both schools can partner to develop new technologies. The success of this research will foster ties between the two campuses,” Wilson said.
“It makes me extremely proud to have contributed to a product with potential to help many people,” he said.
Culp received an $8,000 grant from UAMS that provided him with the materials he needed to experiment. Wilson and Culp completed their first patent for “ultrasound for augmented clot lysis” in 2005. The patent was licensed in 2006 and has been in development by Cerevast Therapeutics.
The ClotBust ER® has 16 transducers scattered around the inside – designed to line up with the thin points in the skull: the temples and the foramen magnum in the base of the skull.
This allows the ultrasound waves to move through the brain without interruption. After the patient is administered an IV containing t-PA, the circular device is placed onto the patient’s head like a sports visor or halo.
“The idea is to deliver ultrasound wherever the clot is and where the IV t-PA is working,” Culp said. “It makes t-PA work better – improving the clot-busting drug by 40 or 50 percent. It’s like taking a cooking pot and stirring it. The ultrasound stirs the drug around, making it work better.”
The clot disappears more quickly. “If we resupply blood, we resupply oxygen. The brain recovers quicker. Quicker is, of course, better,” Culp said.
The Latest on: Stroke treatment
via Google News
The Latest on: Stroke treatment
- Here's how traumatic brain injuries can increase stroke risk for up to 5 yearson April 22, 2021 at 12:46 am
A new study suggests that stroke risk for patients with traumatic brain injuries is at its highest in the four months following injury and remains significant for up to five years post-injury.
- Hemorrhagic Stroke Treatment Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2027on April 21, 2021 at 11:16 pm
The global hemorrhagic stroke treatment market size is expected to experience a substantial growth during the forecast period. The growth is attributable to the increasing incidence of hemorrhagic ...
- Black Patients Less Likely to Receive Acute Stroke Treatmenton April 21, 2021 at 3:45 pm
Racial disparities in the administration of thrombolysis and endovascular therapy were inconsistent among states. However, insurance status was consistently associated with the likelihood of treatment ...
- Stem cell therapy promotes recovery from stroke and dementia in miceon April 21, 2021 at 1:02 pm
A one-time injection of an experimental stem cell therapy can repair brain damage and improve memory function in mice with conditions that replicate human strokes and dementia, a new UCLA study finds.
- Double-dose statin treatment may reduce incidence of post-stroke epilepsyon April 21, 2021 at 2:50 am
Seizure following an acute stroke occurs infrequently but represents a worrisome development. In a recent study, researchers have found that a double dose of statin treatment during the acute phase of ...
- How to Tell the Difference Between Migraine and Strokeon April 20, 2021 at 7:07 am
Some symptoms of migraine and stroke may feel similar, so it makes sense to be concerned. Learn about the similarities and differences of migraine and stroke, as well as possible links between these ...
- In-ambulance consults can shorten the time between stroke symptom onset and treatmenton April 19, 2021 at 11:49 am
By changing EMS workflows and incorporating telemedicine techniques, physicians at MUSC Health have partnered with Georgetown Memorial Hospital and Hampton Regional Medical Center to significantly ...
- In-ambulance consults cut down on critical treatment time for stroke patientson April 19, 2021 at 10:16 am
Through MUSC Health's Telestroke Network, emergency medical technicians (EMTs) can video chat with stroke specialists to begin a patient's consult before they even arrive at the hospital. "We realized ...
- Breakthrough stroke treatment saves Troy man’s lifeon April 18, 2021 at 2:03 pm
A new procedure at Baptist Medical Center South saved a patient from the effects of a stroke by removing a blood clot from his brain.
- Pinocembrin attenuates hemorrhagic transformation after delayed t-PA treatment in thromboembolic stroke rats by regulating endogenous metaboliteson April 15, 2021 at 9:19 am
Hemorrhagic transformation after ischemic stroke in animals and humans. J Cereb Blood Flow Metab. 2014;34:185–99. Kanazawa M, Takahashi T, Nishizawa M, Shimohata T. Therapeutic strategies to attenuate ...
via Bing News